Prevention of hip fractures: Drug therapy
- 31 March 1996
- Vol. 18 (3) , S159-S163
- https://doi.org/10.1016/8756-3282(95)00497-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodelingThe American Journal of Medicine, 1995
- The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 1995
- Why elderly women should be screened and treated to prevent osteoporosisThe American Journal of Medicine, 1995
- Estrogen Replacement Therapy and Fractures in Older WomenAnnals of Internal Medicine, 1995
- Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly womenBMJ, 1994
- Hormonal Treatment of Postmenopausal WomenNew England Journal of Medicine, 1994
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.Journal of Clinical Investigation, 1993
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989